Search research articles
Contact Us
Filters
Showing results (51-60 of 70) with videos related to
Page
of 7
Sort By:
Current Oncology (Toronto, Ont.)
|
June 23, 2022
A Pan-Canadian Consensus Statement on First-Line PARP Inhibitor Maintenance for Advanced, High-Grade Serous and Endometrioid Tubal, Ovarian, and Primary Peritoneal Cancers
Anna V Tinker, Alon D Altman, Marcus Q Bernardini, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
July 27, 2012
Architectural patterns of ovarian/pelvic high-grade serous carcinoma
Amy B Bromley, Alon D Altman, Pamela Chu, et al.
American Journal of Obstetrics and Gynecology
|
July 28, 2020
Guidelines for vulvar and vaginal surgery: Enhanced Recovery After Surgery Society recommendations
Alon D Altman, Magali Robert, Robert Armbrust, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
April 6, 2013
The diagnostic utility of TP53 and CDKN2A to distinguish ovarian high-grade serous carcinoma from low-grade serous ovarian tumors
Alon D Altman, Gregg S Nelson, Prafull Ghatage, et al.
Gynecologic Oncology
|
July 8, 2022
Olaparib treatment for platinum-sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency status: Phase II LIGHT study primary analysis
Karen Cadoo, Fiona Simpkins, Cara Mathews, et al.
American Journal of Obstetrics and Gynecology
|
May 4, 2019
International validation of Enhanced Recovery After Surgery Society guidelines on enhanced recovery for gynecologic surgery
Lena Wijk, Ruzan Udumyan, Basile Pache, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 7, 2026
Pre-operative positron emission tomography scan is associated with lower rates of adjuvant treatment in surgically treated patients with cervical cancer: a 4C Working Group study
Xinye Serena Wang, Gregory R Pond, Sabrina Piedimonte, et al.
Cancer
|
January 16, 2025
Olaparib as treatment for platinum-sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency: Phase 2 LIGHT study final overall survival analysis
Ying L Liu, Cara A Mathews, Fiona Simpkins, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)
|
February 27, 2026
Enumeration, Phenotyping, and Clinical Associations of Tissue-Resident T Cells in the Ecto- and Endocervix of Women Attending a Colposcopy Clinic
Aloysious Ssemaganda, Nyambura Kahia, Myo Minn Oo, et al.
Gynecologic Oncology
|
February 9, 2016
Treatment related outcomes in high-risk endometrial carcinoma: Canadian high risk endometrial cancer consortium (CHREC)
Marcus Q Bernardini, Lilian T Gien, Susie Lau, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 70) with videos related to
Sort By:
Page
of 7
Current Oncology (Toronto, Ont.)
|
June 23, 2022
A Pan-Canadian Consensus Statement on First-Line PARP Inhibitor Maintenance for Advanced, High-Grade Serous and Endometrioid Tubal, Ovarian, and Primary Peritoneal Cancers
Anna V Tinker, Alon D Altman, Marcus Q Bernardini, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
July 27, 2012
Architectural patterns of ovarian/pelvic high-grade serous carcinoma
Amy B Bromley, Alon D Altman, Pamela Chu, et al.
American Journal of Obstetrics and Gynecology
|
July 28, 2020
Guidelines for vulvar and vaginal surgery: Enhanced Recovery After Surgery Society recommendations
Alon D Altman, Magali Robert, Robert Armbrust, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
April 6, 2013
The diagnostic utility of TP53 and CDKN2A to distinguish ovarian high-grade serous carcinoma from low-grade serous ovarian tumors
Alon D Altman, Gregg S Nelson, Prafull Ghatage, et al.
Gynecologic Oncology
|
July 8, 2022
Olaparib treatment for platinum-sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency status: Phase II LIGHT study primary analysis
Karen Cadoo, Fiona Simpkins, Cara Mathews, et al.
American Journal of Obstetrics and Gynecology
|
May 4, 2019
International validation of Enhanced Recovery After Surgery Society guidelines on enhanced recovery for gynecologic surgery
Lena Wijk, Ruzan Udumyan, Basile Pache, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 7, 2026
Pre-operative positron emission tomography scan is associated with lower rates of adjuvant treatment in surgically treated patients with cervical cancer: a 4C Working Group study
Xinye Serena Wang, Gregory R Pond, Sabrina Piedimonte, et al.
Cancer
|
January 16, 2025
Olaparib as treatment for platinum-sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency: Phase 2 LIGHT study final overall survival analysis
Ying L Liu, Cara A Mathews, Fiona Simpkins, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)
|
February 27, 2026
Enumeration, Phenotyping, and Clinical Associations of Tissue-Resident T Cells in the Ecto- and Endocervix of Women Attending a Colposcopy Clinic
Aloysious Ssemaganda, Nyambura Kahia, Myo Minn Oo, et al.
Gynecologic Oncology
|
February 9, 2016
Treatment related outcomes in high-risk endometrial carcinoma: Canadian high risk endometrial cancer consortium (CHREC)
Marcus Q Bernardini, Lilian T Gien, Susie Lau, et al.
Page
of 7